Search

BI Focuses COVID-19 Clinical Research on Alteplase

BI focuses its COVID-19 therapy research on the development of alteplase as a potential treatment for COVID-19 patients with severe breathing problems

Poultry

Gallimune® / Gallivac® / Volvac®

For vaccination of healthy chickens against diseases caused by the included antigens.

Collaboration-with-OxfordBioTherapeutics

Boehringer Ingelheim collaborates with Oxford BioTherapeutics to discover tumor targets to deliver first-in-class treatments for cancer patients.

Vetera

For vaccination of healthy horses as an aid in the prevention of diseases caused by the included antigens (US and Canada only).

Pets

Recombitek®

Recombitek® offers a complete line of canine vaccines against distemper, major circulating strains CPV-2a, 2b, 2c, prevention of disease and shedding against leptospirosis.

Newxxitek™ HVT+ND

The vaccination of 18 to 19-day-old embryos and one-day-old chickens is effective against Marek’s disease and Newcastle disease.

All hands-on deck to fight the ‘zombie’ rabies virus

We’re teaming up with communities and governments across Southeast Asia to fight rabies through vaccinations, education programs, and partnerships.

Pyramid® / Presponse®

The pyramid®/presponse® family of vaccines provides broad coverage for BVD types 1 and 2, IBR, BRSV, PI3 and Mannheimia haemolytica with only a single dose.

Ruminants

Real stories, real impact: fighting rabies

The danger of rabies is often overlooked. The need for action, unseen. Learn how we can eliminate rabies through leveraging education and dog vaccinations.

The Research Process

COVID-19

As a research-driven company, we are part of the collective effort in fighting COVID-19. Learn more about our ongoing engagement in the fight against COVID-19

Veterinary Public Health

Ileitis prevention vaccination Lawsonia intracellularis pig

Cause, impact and prevention: Learn the essentials about Ileitis

Avian influenza prevention at the source

Teshome Mebatsion, Head of Viral Diseases Research at Boehringer Ingelheim, talks about the avian influenza virus, ways of prevention and scenarios for the future.

World Rabies Day: BI fights rabies misconceptions

Boehringer Ingelheim joins efforts to fight rabies under this year’s theme for World Rabies Day to raise awareness of the disease and its prevention.

Closing healthcare gaps with continued vaccination campaigns

How we continue combating rabies through collaborative efforts and the use of drone delivery in rural Kenya.

Innovation and drone delivery

Addressing healthcare disparities through collaborative innovation and drone delivery

Rabies wildlife 5 things to know

Rabies in wildlife - 5 things to know to protect yourself and your pet

Action makes the difference in poultry farms

Farmers, be on the lookout to protect chickens against the ILT virus!

Rabisin® / Imrab®

Rabisin® is used for the active immunisation of dogs and cats to reduce mortality and clinical signs due to rabies infection.

Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio

Rabisin® / Raboral V-RG®